National Health (Originator Brand) Amendment Determination 2019 (No. 7) (PB 82 of 2019) (Cth)

Case

PB 82 of 2019

National Health (Originator Brand) Amendment Determination 2019 (No. 7)

National Health Act 1953

I, THEA DANIEL, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under subsection 99ADB (6B) of the National Health Act 1953.

Dated   30 September 2019

THEA DANIEL

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

  1. Name of Determination

(1)     This Determination is the National Health (Originator Brand) Amendment Determination 2019 (No. 7).

(2)     This Determination may also be cited as PB 82 of 2019.

  1. Commencement

This Determination commences on 1 October 2019.

  1. Amendments to PB 100 of 2015

Schedule 1 amends the National Health (Originator Brand) Determination 2015 (PB 100 of 2015).

Schedule 1     Amendments

(section 3)

[1]                   Schedule 1, (table item 88A and 88B)

Repeal the items:

88A Fluticasone Flixotide
Flixotide Accuhaler
Flixotide Junior
Flixotide Junior Accuhaler
88B Fluticasone with Salmeterol Seretide Accuhaler 100/50
Seretide Accuhaler 250/50
Seretide Accuhaler 500/50
Seretide MDI 50/25
Seretide MDI 125/25
Seretide MDI 250/25

Substitute:

88A Fluticasone propionate Flixotide
Flixotide Accuhaler
Flixotide Junior
Flixotide Junior Accuhaler
88B Fluticasone propionate with salmeterol Seretide Accuhaler 100/50
Seretide Accuhaler 250/50
Seretide Accuhaler 500/50
Seretide MDI 50/25
Seretide MDI 125/25
Seretide MDI 250/25

[2]                   Schedule 1, (after table item 114A)

Insert:

114B Insulin glargine Lantus
Lantus SoloStar
Toujeo SoloStar

[3]                   Schedule 1, (table item 204 and 204A)

Repeal the items:

204 Risperidone Risperdal
Risperdal Quicklet
Risperdal Consta
204A Rivastigmine Exelon Oral
Exelon Patch 5
Exelon Patch 10
Exelon Patch 15
Transdermal
204A Rizatriptan Maxalt

Substitute:

204 Risperidone Risperdal
Risperdal Quicklet
Risperdal Consta
204A Rituximab Mabthera
Mabthera SC
204B

Rivastigmine

Exelon Oral
Exelon Patch 5
Exelon Patch 10
Exelon Patch 15
Transdermal
204C Rizatriptan Maxalt
Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0